P581: Age-related patterns in biological therapy use and surgery among patients with IBD: Insights from the Belgian PANTHER cohortECCO'24Year: 2024
Authors: Celis, J.(1)*;Truyens, M.(2);Verstockt, S.(3);Glorieus, E.(2);De Wolf, M.(4);Lenfant, M.(3);Barbaraci, M.(4);Sabino, J.(3);Ferrante, M.(5);Geldof, J.(2);Verstockt, B.(5);Laukens, D.(1);Cleynen, I.(6);Vandermeulen, L.(4);Vermeire, S.(5);Lobaton, T.(2);
(1)Ghent University, Internal Medicine and Pediatrics, Ghent, Belgium;(2)University Hospital of Ghent, Gastroenterology, Ghent, Belgium;(3)KU Leuven, Chronic Diseases and Metabolism CHROMETA, Leuven, Belgium;(4)Universitair Ziekenhuis Brussel UZ Brussel, Gastroenterology, Brussels, Belgium;(5)University Hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium;(6)KU Leuven, Human Genetics, Leuven, Belgium;IBD Research Unit
P582: Combination of granulocyte–monocyte apheresis and ustekinumab: multicentre and retrospective studyECCO'24Year: 2024
Authors: Rodríguez-Lago, I.(1)*;Herrera-deGuise, C.(2);Boscá-Watts, M.(3);Rodríguez, C.(4);Leo, E.(5);Calvo, M.(6);Cañete, F.(7);Chacón, S.(8);Cuarán, C.(9);Elorza, A.(1);Guerra, E.(10);Iglesias, E.(11);Sánchez, D.(12);Barreiro-de Acosta, M.(13);Ginard, D.(14);Cabriada, J.L.(1);
(1)Hospital Universitario de Galdakao, Gastroenterology Department, Galdakao, Spain;(2)Hospital Universitari Vall d@E@Hebron, Gastroenterology Department, Barcelona, Spain;(3)Hospital Clínico Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(4)Hospital Universitario de Navarra, Gastroenterology Department, Pamplona, Spain;(5)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(6)Hospital San Pedro, Gastroenterology Department, Logroño, Spain;(7)Hospital Universitari Germans Trias i Pujol, Gastroenterology Department, Badalona, Spain;(8)Hospital General Universitario Morales Meseguer, Gastroenterology Department, Murcia, Spain;(9)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(10)Hospital Universitario de Gran Canaria Dr. Negrín, Gastroenterology Department, Las Palmas, Spain;(11)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(12)Hospital Universitario Virgen de las Nieves, Gastroenterology Department, Granada, Spain;(13)Hospital Clínico Universitario de Santiago, Gastroenterology Department, Santiago de Compostela, Spain;(14)Hospital Universitario Son Espases, Gastroenterology Department, Palma, Spain;
P583: Infliximab Monitoring in Crohn@E@s Disease and Development of Neural Networks Using Clinical Variables to Predict Disease Activity and ImmunogenicityECCO'24Year: 2024
Authors: Gomes, L.E.M.(1);Genaro, L.M.(1)*;Castro, M.M.(1);Pascoal, L.B.(1);Ricci, R.L.(1);Silva, F.B.C.(1);Camargo, M.G.(1);Bonfitto, P.H.L.(1);Ayrizono, M.L.S.(1);Azevedo, A.T.(2);Leal, R.F.(1);
(1)Inflammatory Bowel Disease Research Laboratory- Gastrocenter- Colorectal Surgery Unit- School of Medical Sciences- University of Campinas Unicamp, Department of Surgery, Campinas, Brazil;(2)Simulation Laboratory- School of Applied Sciences- University of Campinas Unicamp, Simulation Laboratory, Limeira, Brazil;
P584: Complication rates after two-stage vs three-stage restorative proctocolectomy with ileoanal pouch construction in the era of biologicsECCO'24Year: 2024
Authors: Doyon , F.(1);Saifi , M.(1)*;Doyon , A.(2);Kienle , P.(1);
(1)Theresienkrankenhaus und Diako gGmbH, General and Visceral Surgery, Mannheim, Germany;(2)University Hospital Heidelberg, Center for Pediatrics and Adolescent Medicine, Heidelberg, Germany;
P585: Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab FailureECCO'24Year: 2024
Authors: Bae, J.H.(1);Park, J.B.(1);Baek, J.E.(1);Hong, S.W.(1);Park, S.H.(1,2);Yang, D.H.(1);Ye, B.D.(1,2);Byeon, J.S.(1);Myung, S.J.(1);Yang, S.K.(1,2);Hwang, S.W.(1,2)*;
(1)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology and Internal medicine, Seoul, Korea- Republic Of;(2)University of Ulsan College of Medicine- Asan Medical Center, Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;
P586: Influence of HLA-DQA1∗05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice.ECCO'24Year: 2024
Authors: Pérez Pérez, J.(1)*;Escobar Ortiz, J.(1);Franco Moreno, A.I.(2);Plaza Santos, M.D.R.(1);Castillo Pradillo, M.(1);Ponferrada Díaz, Á.(1);
(1)Infanta Leonor University Hospital, Gastroenterology and Hepatology, Madrid, Spain;(2)Infanta Leonor University Hospital, Internal Medicine, Madrid, Spain;
P587: Development and Characterization of a Novel Extended Half-life Monoclonal Antibody Drug Candidate Targeting Integrin ɑ4β7 for the Treatment of IBDECCO'24Year: 2024
Authors: Zhu, E.(1);Rios, D.(2);Vaz, R.(3);Friedman, J.(4)*;Nguyen, D.(5);Spencer, A.(6);Shaheen, H.(7);Oh, J.(2);
(1)Paragon Therapeutics, Biotherapeutics Discovery, Waltham- MA, United States;(2)Paragon Therapeutics, Biology, Waltham- MA, United States;(3)Paragon Therapeutics, Program and Alliance Management, Waltham- MA, United States;(4)Spyre Therapeutics, Clinical Development, Ardmore, United States;(5)Spyre Therapeutics, Clinical Development, Waltham- MA, United States;(6)Spyre Therapeutics, Nonclinical Development, Waltham- MA, United States;(7)Paragon Therapeutics, Research, Waltham- MA, United States;
P588: Evolution and management of inflammatory joint pathology with non-anti-TNF therapies in inflammatory bowel diseaseECCO'24Year: 2024
Authors: Gonzalez Diaz, I.(1)*;Suarez Ferrer , C.(2);Plasencia Rodriguez, C.(3);Gutierrez, M.(3);Rueda Garcia , J.L.(2);Martin-Arranz, E.(2);Poza Cordon, J.(2);Sanchez-Azofra, M.(2);Amor Costa , C.(1);Amiama Roig, C.(1);Martin-Arranz, M.D.(4);
(1)Hospital La Paz, Gastroenterology and Hepatology, Madrid, Spain;(2)Hospital La Paz Institute for Health Research – IdiPAZ La Paz University Hospital, Gastroenterology and Hepatology, Madrid, Spain;(3)Hospital La Paz, Rheumatologist, Madrid, Spain;(4)Hospital La Paz Institute for Health Research – IdiPAZ La Paz University Hospital – Universidad Autónoma de Madrid, Gastroenterology and Hepatology, Madrid, Spain;
P589: Real-world data on upadacitinib in the treatment of inflammatory bowel disease: safe and highly effective with extremely positive patient feedbackECCO'24Year: 2024
Authors: Harris, C.(1)*;Gee, T.(1);Barcan, A.(2);Yanagisawa, Y.(2);Brown, M.(2);Gordon, J.N.(1);
(1)Hampshire Hospitals NHS Foundation Trust Royal Hampshire County Hospital, Gastroenterology, Winchester, United Kingdom;(2)Hampshire Hospitals NHS Foundation Trust Basingstoke and North Hampshire Hospital, Gastroenterology, Basingstoke, United Kingdom;
P590: Use of upadacitinib in Refractory Paediatric Inflammatory Bowel Diseasein: A Single-Center Cohort StudyECCO'24Year: 2024
Authors: Potapov, A.(1)*;Vinokurova , A.(2);Pushkareva , A.(3);Prokhorenkova, M.(3);Anushenko , A.(4);Fisenko, A.(5);
(1)National Medical Research Center for Childrens Health, Department of Gastroenterology, Moscow, Russian Federation;(2)National Medical Research Center for Children@E@s Health- -, Department of Gastroenterology, Moscow, Russian Federation;(3)I.M. Sechenov First Moscow State Medical University Sechenov University, Department of Pediatrics and Pediatric Rheumatology, Moscow, Russian Federation;(4)National Medical Research Center for Children@E@s Health, Department of Gastroenterology, Moscow, Russian Federation;(5)National Medical Research Center for Children@E@s Health, director, Moscow, Russian Federation;
P592: Higher predictive power of epigenetic signatures for response to vedolizumab and ustekinumab in anti-TNF naïve patients with active Crohn’s diseaseECCO'24Year: 2024
Authors: Van Zon, S.(1)*;Joustra*, V.(1);Li Yim*, A.Y.F.(2);Henneman, P.(3);Hageman, I.(1);de Waard, T.(4);Levin, E.(4);Noble, A.(5);Chapman, T.(5,6);McGregor, C.(5);Adams, A.(5);Satsangi**, J.(5);de Jonge**, W.J.(2,7);D@E@Haens**, G.R.(1);
(1)Amsterdam UMC - University of Amsterdam, Department of Gastroenterology & Hepatology, Amsterdam, The Netherlands;(2)Amsterdam UMC - University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands;(3)Amsterdam UMC - University of Amsterdam- Genome Diagnostics Laboratory, Department of Human Genetics, Amsterdam, The Netherlands;(4)Horaizon, bv, Delft, The Netherlands;(5)Oxford University Hospitals NHS Foundation Trust - John Radcliffe Hospital, Translational Gastroenterology Unit & NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom;(6)St Richard’s and Worthing Hospitals- University Hospitals Sussex NHS Foundation Trust, Department of Gastroenterology, West Sussex, United Kingdom;(7)University of Bonn, Department of Surgery, Bonn, Germany;
P593: Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 StudiesECCO'24Year: 2024
Authors: Panaccione, R.(1)*;Louis, E.(2);Colombel, J.F.(3);D@E@Haens, G.(4);Peyrin-Biroulet, L.(5);Dubinsky, M.(6);Takeuchi , K.(7);Kalabic, J.(8);Levine, P.(9);Neimark, E.(9);Chen, S.(9);Cheng, L.(9);Duan, W.R.(9);Vladea, R.(9);Hecht, P.M.(9);Sanchez Gonzalez , Y.(9);Schreiber, S.(10);Ferrante, M.(11);
(1)University of Calgary, Inflammatory Bowel Disease Unit- Division of Gastroenterology and Hepatology, Alberta, Canada;(2)University Hospital CHU of Liège, Hepato-Gastroenterology and Digestive Oncology Department, Liège, Belgium;(3)Icahn School of Medicine at Mount Sinai, Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States;(4)Amsterdam University Medical Centres, Department of Gastroenterology, Amsterdam, Netherlands Antilles;(5)University Hospital of Nancy- Lorraine University, Department of Gastroenterology and INSERM- U1256NGERE- Faculty of Medicine-, Vandoeuvre, France;(6)Icahn School of Medicine at Mount Sinai, Department of Pediatrics- Inflammatory Bowel Disease Center, New York, United States;(7)Tsujinaka Hospital Kashiwanoha, Division of Gastroenterology and Hepatology, Chiba, Japan;(8)AbbVie Deutschland GmbH & Co. KG, none, Ludwigshafen, Germany;(9)AbbVie, none, North Chicago, United States;(10)University Hospital Schleswig-Holstein- Christian Albrechts University, Department Internal Medicine, Kiel, Germany;(11)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P594: One-year success rates of targeted therapy in Ulcerative Colitis patients revisitedECCO'24Year: 2024
Authors: Creemers, R.(1)*;van Andel, E.(2);Wintjens, D.(1);van Bodegraven, A.(1);
(1)Zuyderland Medical Centre, Department of Gastroenterology- Geriatrics- Internal and Intensive Care Medicine Co-MIK, Heerlen-Sittard-Geleen, The Netherlands;(2)Noordwest Ziekenhuisgroep, Department of Gastroenterology and Hepatology, Alkmaar, The Netherlands;
P595: Assessment of mucosal healing after exclusive elemental diet using small bowel capsule endoscopy in paediatric Crohn’s diseaseECCO'24Year: 2024
Authors: Kim, Y.E.(1)*;Choi, H.J.(1);Jang, J.Y.(1);Lee, S.H.(1);Kim, D.Y.(2);Oh, S.H.(1);Kim, K.M.(1);
(1)Asan Medical Center Children’s Hospital- University of Ulsan College of Medicine, Department of Pediatrics, Seoul, Korea- Republic Of;(2)Asan Medical Center- University of Ulsan College of Medicine, Division of Pediatric Surgery- Department of Surgery, Seoul, Korea- Republic Of;
P597: The changing landscape of paediatric Inflammatory Bowel Disease medication in Australia 2015-2021, A population-based studyECCO'24Year: 2024
Authors: Gawade, G.(1);Massuger, W.(2);Giles, E.(1,3)*;
(1)Monash University, Department of Paediatrics, Clayton, Australia;(2)Crohn@E@s & Colitis Australia, Crohn@E@s & Colitis Australia, Camberwell, Australia;(3)Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Disease, Clayton, Australia;
P598: Validating and Enhancing Real-time Disease Severity Classification in Ulcerative Colitis: Artificial Intelligence as a Second Opinion TriggerECCO'24Year: 2024
Authors: Lo, B.Z.S.(1,2)*;Møller, B.(3);Igel, C.(3);Wildt, S.(1,2);Vind, I.(1,2);Bendtsen, F.(1,2);Burisch, J.(1,2);Bulat, I.(3);
(1)Copenhagen University Hospital – Amager and Hvidovre, Gastro Unit- Medical Section, Hvidovre, Denmark;(2)Copenhagen University Hospital – Amager and Hvidovre, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents and Adults, Hvidovre, Denmark;(3)University of Copenhagen, Department of Computer Science, Copenhagen, Denmark;
P599: An Antioxidant diet in comparison to a Mediterranean diet for children and adults with Inflammatory Bowel Disease: clinical outcomes and nutritional data from OXIBDiet trialECCO'24Year: 2024
Authors: Quattrini, S.(1)*;Galeazzi, T.(1);Greco, A.(1);Fioroni, M.C.(1);Mattioli, S.(1);Monachesi, C.(1);Cianfruglia, L.(2);Romaldi, B.(2);Catassi, G.(3);Quatraccioni, C.(4);Di Sario, A.(5);Armeni, T.(2);Catassi, C.(1);Gatti, S.(1);
(1)Polytechnic University of Marche, Department of Pediatrics, Ancona, Italy;(2)Polytechnic University of Marche, Department of Clinical Sciences, Ancona, Italy;(3)Sapienza- University of Rome, Department of Pediatrics, Rome, Italy;(4)Polytechnic University of Marche, Department of Gastroenterology, Ancona, Italy;(5)Area vasta n.2 - Senigallia, Department of Gastroenterology, Senigallia, Italy;
P600: Efficacy of different modalities of faecal microbiota transplantation to induce clinical remission in patients with ulcerative colitis: a systematic review and network meta-analysisECCO'24Year: 2024
Authors: Chapon, J.(1);Scanzi, J.(1);Pereira, B.(1);Sokol, H.(2);Buisson, A.(1)*;
(1)CHU Clermont-Ferrand, IBD Unit, Clermont-Ferrand, France;(2)AP-HP, IBD Unit, Paris, France;
P601: Intestinal ultrasound correlates with clinical, biochemical, endoscopic and histologic biomarkers in patients with Ulcerative Colitis: a cross-sectional studyECCO'24Year: 2024
Authors: Bravo, A.(1)*;Revés, J.(1);Nascimento, C.(1);Abreu, B.(1);Bargas, A.(1);Bragança, S.(2);Rafael, M.A.(2);Estevinho, M.(3);Silva, J.(3);Guedes, A.(1);Borralho, P.(4);Glória, L.(1);Roque Ramos, L.(1);Palmela, C.(1);Torres, J.(1,5);Frias-Gomes, C.(1);
(1)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(2)Hospital Prof. Doutor Fernando da Fonseca, Division of Gastroenterology, Amadora, Portugal;(3)Centro Hospitalar Vila Nova de Gaia/Espinho, Division of Gastroenterology, Vila Nova de Gaia, Portugal;(4)Hospital CUF Descobertas, Division of Anatomic Pathology, Lisboa, Portugal;(5)Hospital da Luz, Division of Gastroenterology, Lisboa, Portugal;
